Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 121
Filter
1.
Indian J Clin Biochem ; 32(3): 261-265, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28811684

ABSTRACT

Lead exposure is increasingly becoming an important risk factor for osteoporosis. In adults, approximately 80-90 % of absorbed lead is stored in the bones. These bone lead deposits are released into the blood during periods of enhanced bone resorption like menopause, forming a potential endogenous source of lead exposure. Postmenopausal women are at a higher risk for bone lead release because of hormonal and age related changes in bone metabolism. Estrogen deficiency is associated with increase in osteoclasts number and activity leading to both the early and late form of osteoporosis. Hence, high blood lead level coupled with concomitant environmental exposure exposes women in this age group to lead related adverse outcomes like hypertension, reduced kidney and neurocognitive functions as well as increased risk of atherosclerosis and cardiovascular mortality. A few studies have also identified coexisting variates like ethnicity, occupation, residence, education, smoking, alcohol medications, water etc. as significant determinants of bone and blood lead in women, thus increasing the magnitude of postmenopausal bone changes. Hence, interventions focused on reducing the intensity of bone resorption during menopause will help decrease exposure to endogenous lead. This would play a significant role in decreasing the morbidity and mortality associated with menopause. Also, identification of modifiable factors that prevent bone lead release will reduce the risk of chronic lead exposure and improve the health outcomes of post-menopausal women.

2.
Indian J Clin Biochem ; 31(2): 148-51, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27069322

ABSTRACT

Hyperhomocysteinemia (HHCY) has been demonstrated to affect cochlear microvasculature as well as cochlear epithelial cells directly, with a resultant alteration of the expression of matrix metalloproteinases (MMPs) and their inhibitors, tissue inhibitors of metalloproteinases (TIMPs). Hence, ascertaining the optimum concentration of MMPs and TIMPs in the cochlea could help to inhibit hearing loss due to HHCY by the administration of appropriate MMP inhibitors, Since infections/inflammations as well as ototoxic antibiotics have a similar mechanism of otic pathology, the cochlear damage they cause could also be similarly prevented.

3.
Indian J Clin Biochem ; 31(1): 13-20, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26855483

ABSTRACT

The current epidemic affecting Indians is coronary artery disease (CAD), and is currently one of the most common causes of mortality and morbidity in developed and developing countries. The higher rate of CAD in Indians, as compared to people of other ethnic origin, may indicate a possible genetic susceptibility. Hence, Lp(a), an independent genetic risk marker for atherosclerosis and cardiovascular disease assumes great importance. Lp(a), an atherogenic lipoprotein, contains a cholesterol rich LDL particle, one molecule of apolipoprotein B-100 and a unique protein, apolipoprotein (a) which distinguishes it from LDL. Apo(a) is highly polymorphic and an inverse relationship between Lp(a) concentration and apo(a) isoform size has been observed. This is genetically controlled suggesting a functional diversity among the apo(a) isoforms. The LPA gene codes for apo(a) whose genetic heterogeneity is due to variations in its number of kringles. The exact pathogenic mechanism of Lp(a) is still not completely elucidated, but the structural homology of Lp(a) with LDL and plasmin is possibly responsible for its acting as a link between atherosclerosis and thrombosis. Upper limits of normal Lp(a) levels have not been defined for the Indian population. A cut off limit of 20 mg/dL has been suggested while for the Caucasian population it is 30 mg/dL. Though a variety of assays are available for its measurement, standardization of the analytical method is highly complicated as a majority of the methods are affected by the heterogeneity in apo(a) size. No therapeutic drug selectively targets Lp(a) but recently, new modifiers of apo(a) synthesis are being considered.

4.
Am J Clin Nutr ; 102(5): 1030-4, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26310540

ABSTRACT

BACKGROUND: In utero latent iron deficiency has been associated with abnormal neurodevelopmental outcomes during childhood. Its concomitant effect on auditory neural maturation has not been well studied in late preterm and term infants. OBJECTIVE: The objective was to determine whether in utero iron status is associated with auditory neural maturation in late preterm and term infants. DESIGN: This prospective cohort study was performed at Sir Ganga Ram Hospital, New Delhi, India. Infants with a gestational age ≥34 wk were eligible unless they met the exclusion criteria: craniofacial anomalies, chromosomal disorders, hemolytic disease, multiple gestation, third-trimester maternal infection, chorioamnionitis, toxoplasmosis, other infections, rubella, cytomegalovirus infection, and herpes simplex virus infections (TORCH), Apgar score <5 at 5 min, sepsis, cord blood not collected, or auditory evaluation unable to be performed. Sixty consecutive infants with risk factors for iron deficiency, such as small for gestational age and maternal diabetes, and 30 without risk factors for iron deficiency were enrolled. Absolute wave latencies and interpeak latencies, evaluated by auditory brainstem response within 48 h after birth, were measured and compared between infants with latent iron deficiency (serum ferritin ≤75 ng/mL) and infants with normal iron status (serum ferritin >75 ng/mL) at birth. RESULTS: Twenty-three infants had latent iron deficiency. Infants with latent iron deficiency had significantly prolonged wave V latencies (7.10 ± 0.68 compared with 6.60 ± 0.66), III-V interpeak latencies (2.37 ± 0.64 compared with 2.07 ± 0.33), and I-V interpeak latencies (5.10 ± 0.57 compared with 4.72 ± 0.56) compared with infants with normal iron status (P < 0.05). This difference remained significant on regression analyses after control for confounders. No difference was noted between latencies I and III and interpeak latencies I-III. CONCLUSION: Latent iron deficiency is associated with abnormal auditory neural maturation in infants at ≥34 wk gestational age. This trial was registered at clinicaltrials.gov as NCT02503397.


Subject(s)
Anemia, Iron-Deficiency/physiopathology , Auditory Diseases, Central/etiology , Auditory Pathways/physiopathology , Infant, Premature, Diseases/physiopathology , Maternal Nutritional Physiological Phenomena , Neurogenesis , Pregnancy Complications/physiopathology , Anemia, Iron-Deficiency/congenital , Anemia, Iron-Deficiency/diagnosis , Anemia, Iron-Deficiency/epidemiology , Cohort Studies , Delayed Diagnosis , Female , Ferritins/blood , Fetal Blood , Humans , Incidence , India/epidemiology , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/blood , Infant, Premature, Diseases/epidemiology , Male , Pregnancy , Pregnancy Complications/blood , Pregnancy Complications/diagnosis , Pregnancy Complications/epidemiology , Prevalence , Prospective Studies , Risk Factors
5.
Mol Cell Biochem ; 389(1-2): 59-68, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24357117

ABSTRACT

Coronary artery disease (CAD) affects Indians 5-6 years earlier than in the west, is diffuse and malignant, and poses a heavy burden on India's developing economy. Traditional risk factors have failed to explain this high incidence of premature CAD and hence this study investigated the association of two novel risk biomarkers, cystatin C and small dense LDL (sdLDL) with the presence and severity of CAD. Cystatin C and sdLDL were estimated in 204 CAD patients ≤45 years of age and compared with 161 age-matched healthy controls. The traditional lipid profile parameters, i.e., cholesterol, LDL, HDL, triglycerides, apolipoproteins A1 and B, and Lp(a) were also measured in both groups. Cystatin C was significantly raised and mean LDL particle size significantly reduced in CAD patients as compared to controls. 62.7 % of CAD patients showed pattern B while 37.3 % patients showed pattern A. Of the traditional lipid tests, only HDL and apolipoprotein A1 showed a significant decrease in the CAD group. sdLDL was significantly associated with the severity of CAD, while cystatin C was not. Both cystatin C and sdLDL emerged as independent risk factors, however, of the two, sdLDL was a more sensitive predictor of CAD events. Cystatin C and mean LDL particle size are significantly and independently associated with the presence of CAD events in patients ≤45 years with normal kidney function. Hence, these novel risk biomarkers can be useful tools in reducing the morbidity and mortality associated with CAD in the productive Indian workforce.


Subject(s)
Biomarkers/metabolism , Cholesterol, LDL/metabolism , Coronary Artery Disease/etiology , Coronary Artery Disease/metabolism , Cystatin C/metabolism , Adult , Apolipoprotein A-I/metabolism , Apolipoproteins B/metabolism , Cholesterol/metabolism , Cholesterol, HDL/metabolism , Female , Humans , India , Lipoprotein(a)/metabolism , Male , Middle Aged , Particle Size , Risk , Risk Factors , Triglycerides/metabolism
6.
Vascular ; 20(2): 88-95, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22375042

ABSTRACT

Homocysteine is a sulfur-containing amino acid, which is derived from dietary methionine. Hyperhomocysteinemia has been implicated in vascular disease for over a decade now, and can be treated with B vitamins. Among its causes is polymorphism of the MTHFR gene, the most common being the cytidine to thymidine at position 677 (MTHFR C677T), which gives rise to three genotypes - normal homozygous CC, heterozygous CT and homozygous variant TT. An attempt was made to ascertain the prevalence of this MTHFR C677T in our population so that preventive measures may accordingly be instituted. Blood samples from 70 patients with vascular disease and 70 healthy controls were analyzed for plasma homocysteine levels (chemiluminescent immunoassay) and for the presence of MTHFR C677T (polymerase chain reaction analysis). Homocysteine was higher in the homozygous subjects (TT genotype) than in the heterozygous (CT genotype). In patients, the frequency of the C allele was significantly lower, and that of the T allele was significantly higher than the corresponding frequencies in controls. In conclusion, the North Indian urban population has higher homocysteine levels associated with the TT genotype. Hence, instituting measures towards reduction of homocysteine levels in the population would probably reduce the incidence and morbidity of vascular disease in our population.


Subject(s)
Hyperhomocysteinemia/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Polymorphism, Genetic , Vascular Diseases/genetics , Adolescent , Adult , Aged , Biomarkers/blood , Case-Control Studies , Chi-Square Distribution , Female , Gene Frequency , Genetic Predisposition to Disease , Heterozygote , Homocysteine/blood , Homozygote , Humans , Hyperhomocysteinemia/blood , Hyperhomocysteinemia/enzymology , Immunoassay , India , Male , Middle Aged , Phenotype , Polymerase Chain Reaction , Risk Assessment , Risk Factors , Urban Population , Vascular Diseases/blood , Vascular Diseases/enzymology , Young Adult
8.
Mol Cell Biochem ; 285(1-2): 143-7, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16479321

ABSTRACT

The notion that oxidation of lipids and propagation of free radicals may contribute to the pathogenesis of atherosclerosis is supported by a large body of evidence. To circumvent the damage caused by oxygen free radicals, antioxidants are needed which provide the much needed neutralization of free radical by allowing the pairing of electrons. In this study we have investigated the effect of ascorbic acid, a water soluble antioxidant on the development of hypercholesterolemia induced atherosclerosis in rabbits. Rabbits were made hypercholesterolemic and atherosclerotic by feeding 100 mg cholesterol/day. Different doses of ascorbic acid were administered to these rabbits. Low dose of ascorbic acid (0.5 mg/100 g body weight/day) did not have any significant effect on the percent of total area covered by atherosclerotic plaque. However, ascorbic acid when fed at a higher dose (15 mg/100 g body weight/day) was highly effective in reducing the atherogenecity. With this dose the percent of total surface area covered by atherosclerotic plaque was significantly less (p < 0.001). This suggests that use of ascorbic acid may have great promise in the prevention of hypercholesterolemia induced atherosclerosis.


Subject(s)
Ascorbic Acid/pharmacology , Coronary Artery Disease/etiology , Coronary Artery Disease/prevention & control , Hypercholesterolemia/complications , Animals , Antioxidants/administration & dosage , Aorta/anatomy & histology , Aorta/pathology , Ascorbic Acid/administration & dosage , Carotid Stenosis/pathology , Cholesterol/administration & dosage , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Diet, Atherogenic , Hypercholesterolemia/drug therapy , Lipid Peroxidation/drug effects , Malondialdehyde/blood , Rabbits
9.
Indian J Clin Biochem ; 20(1): 201-7, 2005 Jan.
Article in English | MEDLINE | ID: mdl-23105523

ABSTRACT

Biotechnology in India has made great progress in the development of infrastructure, manpower, research and development and manufacturing of biological reagents, biodiagnostics, biotherapeutics, therapeutic and, prophylactic vaccines and biodevices. Many of these indigenous biological reagents, biodiagnostics, therapeutic and prophylactic vaccines and biodevices have been commercialized. Commercially when biotechnology revenue has reached $25 billions in the U.S. alone in 2000 excluding the revenues of biotech companies that were acquired by pharmaceutical companies, India has yet to register a measurable success. The conservative nature and craze of the Indian Industry for marketing imported biotechnology products, lack of Government support, almost non-existing national healthcare system and lack of trained managers for marketing biological and new products seem to be the important factors responsible for poor economic development of biotechnology in India. With the liberalization of Indian economy, more and more imported biotechnology products will enter into the Indian market. The conditions of internal development of biotechnology are not likely to improve in the near future and it is destined to grow only very slowly. Even today biotechnology in India may be called to be in its infancy.

10.
Lupus ; 13(4): 228-33, 2004.
Article in English | MEDLINE | ID: mdl-15176657

ABSTRACT

The decline in the levels of erythrocyte complement receptor 1 (ECR1) in systemic lupus erythematosus (SLE) has been widely reported. The most probable cause for this decline is excessive proteolytic shedding of CR1 from the cell surface. Similarly a decline in glomerular CR1 (GCR1) has also been reported in SLE. Because CR1 is excreted in urine it is imperative to study the relationship of urinary CR1 (uCR1) with ECR1 and GCR1, and their overall correlation with disease activity. We have determined the levels of uCR1, ECR1 and GCR1 in SLE patients and compared them with normal controls and minimal change disease (MCD) patients. We found a significant decline in both uCR1 and GCR1 in SLE but not in MCD; levels of uCR1 in MCD were either comparable to those of controls or higher. Immunofluorescence for GCR1 was very high in MCD. We did not find any correlation between ECR1, uCR1 and kidney function tests on divariate scatter analyses. The correlation coefficient for uCR1 and GCR1 was highly significant and positive. Our findings thus suggest that uCR1 reflects the levels of GCR1 expression, which decline drastically in SLE. Therefore we envisage uCR1 as a potential marker for glomerular involvement in SLE.


Subject(s)
Lupus Erythematosus, Systemic/urine , Receptors, Complement 3b/analysis , Case-Control Studies , Complement C3/metabolism , Erythrocytes/metabolism , Fluorescent Antibody Technique , Humans , Immunoglobulins/metabolism , Kidney Function Tests , Kidney Glomerulus/metabolism , Lupus Erythematosus, Systemic/blood , Nephrosis, Lipoid/blood , Nephrosis, Lipoid/urine , Receptors, Complement 3b/blood , Urine/chemistry
11.
Mol Cell Biochem ; 259(1-2): 59-66, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15124908

ABSTRACT

Various population studies have reported the association of rare S2 allele of apolipoprotein C3 (APOC3) SstI polymorphism with hypertriglyceridemia (HTG) and coronary artery disease (CAD). We were the first to report an association of S2 allele with high triglyceride (TG) levels in healthy volunteers from Northern India. Since HTG is suggested to be a predominant risk factor for CAD among Indians, we have elucidated the relationship of APOC3 SstI polymorphism with the lipid profile and CAD. A total of 158 patients with > or = 70% stenosis in one or more coronary artery (angiographically proven CAD patients), 35 subjects with < 70% stenosis (NCAD) and 151 normal controls (free of heart disease) from Northern plains of India were recruited in the study. DNA samples were analyzed by polymerase chain reaction (PCR) followed by SstI digestion. Lipid profile was estimated by enzymatic kit. We found a strong association of S2 allele with high TG levels, which was more significant in patients. Prevalence of S2 allele in normal controls and CAD patients were comparable, despite the fact that mean TG level was significantly higher in patients. A greater insight into this observation revealed that the prevalence of high TG, if not coupled with other risk factors (like high total cholesterol, low HDL), was comparable in patients and controls. Thus, our study reveals that rare S2 allele may be employed as a susceptibility marker for high TG. However, high TG or S2 allele alone may not contribute to the etiology of CAD.


Subject(s)
Apolipoproteins C/genetics , Coronary Artery Disease/genetics , Genetic Predisposition to Disease , Hypertriglyceridemia/genetics , Adult , Alleles , Apolipoprotein C-III , Coronary Artery Disease/blood , Coronary Artery Disease/etiology , Deoxyribonucleases, Type II Site-Specific , Female , Humans , Hypertriglyceridemia/blood , India , Lipids/blood , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Genetic/genetics , Polymorphism, Restriction Fragment Length , Risk Assessment
12.
Indian J Clin Biochem ; 19(1): 76-8, 2004 Jan.
Article in English | MEDLINE | ID: mdl-23105432

ABSTRACT

Homocysteine (Hcy) is a non-protein forming amino-acid, whose metabolism is at the intersection of two metabolic pathways: remethylation and transsulfuration which are dependent on the vitamins folic acid, B(12) and B(6), and the enzymes methylenetetrahydrofolate reductase and cystathionine-ß-synthetase. A deficiency of any of these vitamins or enzymes results in hyperhomocysteinemia. This causes oxidative and other damage to blood vessels, thus affecting various organ systems of the body. As part of our ongoing research on cardiovascular risk factors, we have studied the Hcy levels in the plasma of normal controls and those suffering from vascular diseases. It was observed that Hcy is significantly higher in patients of vascular diseases (21.59±1.28 µmol/L, mean±SEM), as compared to normal controls (11.33±0.18 µmol/L). This significance, was more pronounced in cases of venous thrombosis (26.77±2.43 µmol/L) as opposed to cases of arterial block (17.27±0.84 µmol/L). This signifies that Hcy estimation would be beneficial in obtaining a differential diagnosis in addition to being a modifiable vascular risk factor.

13.
Indian J Clin Biochem ; 18(2): 34-8, 2003 Jul.
Article in English | MEDLINE | ID: mdl-23105390

ABSTRACT

Several studies including a small case-control (hypertriglyceridemic/normotriglyceridemic individuals) study by us revealed close association between rare S2 allele ofAPOC3 Sstl polymorphism and hypertriglyceridemia. With the understanding that Asian Indians are highly vulnerable to the adverse effects of hypertriglyceridemia, we extended the investigation and studied the frequency distribution of this polymorphism in 216 healthy volunteers from Northern plains of India. We found that more than 50% of the study population had one or two S2 allele. This may suggest that a larger fraction of this population is genetically predisposed to hypertriglyceridemia.

14.
J Commun Dis ; 35(2): 65-70, 2003 Jun.
Article in English | MEDLINE | ID: mdl-15562950

ABSTRACT

The evolution of Mycobacterium tuberculosis as an intracellular pathogen has led to a complex relationship between it and its host, the human mononuclear phagocyte. The products of M. tuberculosis-specific T lymphocytes are essential for macrophage activation for intracellular mycobacterial killing. However, dysfunction cell-mediated immune response to infection with M. tuberculosis may contribute to progressive primary infection or reactivation of endogenous foci of mycobacteria. Th1 cells produce IL-2, which is essential for proper cellular immunity. The aim of this study was to identify the variation in IL-2 activity and soluble IL-2 receptor (IL-2 R) in peripheral blood lymphocyte in patients suffering with pulmonary tuberculosis. A significant decrease in IL-2 and IL-2 receptor level was observed in patients with pulmonary tuberculosis when compared to normal controls. Our results suggested that patients with pulmonary tuberculosis had a defect in IL-2 production. Better understanding of these interactions will allow the development of increasingly specific immune-based interventions for prevention and treatment of tuberculosis.


Subject(s)
Interleukin-2/biosynthesis , Leukocytes, Mononuclear/metabolism , Receptors, Interleukin-2/metabolism , Tuberculosis, Pulmonary/metabolism , Adolescent , Adult , Case-Control Studies , Female , Humans , Male , Middle Aged , Tuberculosis, Pulmonary/blood
15.
BMC Genet ; 3: 9, 2002 Jun 06.
Article in English | MEDLINE | ID: mdl-12052247

ABSTRACT

BACKGROUND: A close association between Sst I polymorphism in the 3' untranslated region of the apolipoproteinC3 (APOC3) gene and levels of plasma triglycerides (TG) had been reported by different investigators. Hypertriglyceridemia(HTG) is a known risk factor for coronary artery disease (CAD) in the context of Asian Indians. We conducted a study on the relationship between APOC3 SstI polymorphism (S1S1, S1S2 and S2S2 genotypes) and plasma TG levels in a group of 139 male healthy volunteers from Northern India. METHODS: DNA samples were analyzed by polymerase chain reaction (PCR) followed by SstI digestion. Digested PCR products were run on 3% agarose gel and visualized by ethidium bromide staining. RESULTS: Rare S2 allele was highly prevalent in our study population (0.313) as compared to the Caucasians (0.00-0.11). The genotypic distribution was in agreement with Hardy-Weinberg equilibrium. S2 allele was almost two times more prevalent in the HTG group (N = 34) as compared to NTG group (N = 105) (p = 0.001). Multiple logistic regression revealed S1S2 individuals had age-adjusted odds ratio of 2.43 (95%CI = 0.99-6.01, p = 0.054) and S2S2 had 9.9 (95%CI = 2.66-37.29, p = 0.0006) for developing HTG in comparison to S1S1 genotype. CONCLUSIONS: Our study shows a significant association between rare S2 allele and HTG in Asian Indians.


Subject(s)
Apolipoproteins C/genetics , Deoxyribonucleases, Type II Site-Specific/genetics , Polymorphism, Genetic/genetics , Triglycerides/blood , Apolipoprotein C-III , Asian People/genetics , Genotype , Humans , Hypertriglyceridemia/blood , Hypertriglyceridemia/epidemiology , Hypertriglyceridemia/genetics , India/epidemiology , Male , Middle Aged , White People/genetics
16.
Mol Cell Biochem ; 232(1-2): 97-102, 2002 Mar.
Article in English | MEDLINE | ID: mdl-12030385

ABSTRACT

Apolipoprotein E (apo E), a genetic determinant of plasma lipid levels and coronary heart disease (CHD) needs to be investigated in Asian Indians since they have a propensity to develop dyslipidemia and accelerated atherosclerosis. We studied apo E phenotypes and plasma lipid levels in 52 Northern Indian male patients (aged 38-71 years) with angiographically proven CHD, and compared them to 50 healthy blood donors taken as the control group. High levels of Lp(a), (p < 0.05), and a definite trend towards lower levels of HDL-C (p < 0.05), was observed in the CHD patients as compared to the control subjects. The frequency of apo E allele epsilon3 was 0.86 and 0.862, and epsilon4 allele was 0.12 and 0.08 in the patients and controls, respectively. However, a lower frequency of the E2 allele was observed in the patient group (E2 = 0.02) as compared to the controls (epsilon2 = 0.06) (p = ns). In individuals with apo E3/E3 phenotype, significantly lower HDL-C levels was observed in the CHD patients as compared to the control subjects (p < 0.05). A positive correlation was observed between apo E phenotypes and Lp(a) levels in the CHD subjects as compared to the controls (p < 0.05), the level being significantly high in CHD subjects with at least one E4 allele. To conclude, in this sample of Northern Indian subjects with CHD, there is a significant correlation between apo E3/E3 phenotype and low levels of HDL-C as compared to the control subjects. Further, apo E phenotype is positively correlated with high Lp(a) levels in the CHD subjects having at least one E4 allele. However, these relationships need to be explored in a larger sample of subjects.


Subject(s)
Apolipoproteins E/blood , Apolipoproteins E/genetics , Coronary Disease/blood , Coronary Disease/genetics , Lipids/blood , Lipoproteins/blood , Polymorphism, Genetic/genetics , Adult , Aged , Gene Frequency , Humans , India , Male , Middle Aged , Phenotype
17.
Indian J Clin Biochem ; 17(1): 99-107, 2002 Jan.
Article in English | MEDLINE | ID: mdl-23105344

ABSTRACT

An elevated level of plasma homocysteine, sulfur containing amino acid generated through demethylation of methionine has been widely accepted as a risk factor for cardiovascular disease (CVD). The increase can result from genetic and/or nutrient related disturbances in the remethylation or transsulfuration pathways for homocysteine metabolism. A common mutation (C677T) in the gene encoding for the enzyme 5, 10-methylenetetrahydrofolate reductase (MTHFR) or deficiency of the B vitamins namely folic acid, B(12), B(6) can lead to hyperhomocysteinemia.In the present study, we have investigated the incidence of the (C677T) MTHFR polymorphism in the North Indian males. 141 angiographically proven coronary artery disease (CAD) patients and 55 age and sex matched healthy volunteers were examined for the association between MTHFR gene polymorphism and CAD. The MTHFR genotyping was performed using polymerase chain reaction (PCR) followed by restriction-isotyping with Hinf 1 endonuclease. A trend for higher 'T' allele frequency (0.19) was observed in patients than in controls (0.16). However no significant association was found between C677T mutation and CAD severity. The lack of statistical significance could be due to the small sample size studied. Hence a larger study including various ethnic groups is warranted.

18.
J Immunoassay Immunochem ; 22(3): 289-97, 2001.
Article in English | MEDLINE | ID: mdl-11506278

ABSTRACT

An ELISA was developed and validated for the quantitation of Complement Receptor 1 (CR1) in human plasma. The ELISA employed a monoclonal anti-CR1 antibody adsorbed onto microtiter plates to capture CR1 in human plasma. The captured CR1 was treated with a detecting antibody which had a different epitopic specificity for CR1. HRP conjugated anti IgG (secondary antibody) was used for quantitation. The standard curve covered a wide range from 10 pg to 800 pg. The inter- and intra-assay variation were found to be low and within the acceptable limits. Specificity and accuracy for the assay was established by ensuring negligible cross reactivity with other proteins and an excellent parallelism between the sample and standard curve. The samples were checked for loss of sCR1 levels through freeze/thaw cycles at different intervals of time stored at -70 degrees C.


Subject(s)
Complement C1/metabolism , Enzyme-Linked Immunosorbent Assay/standards , Receptors, Complement/blood , Cross Reactions , Enzyme-Linked Immunosorbent Assay/methods , Humans , Immune Sera , Receptors, Complement/immunology , Receptors, Complement/metabolism , Reference Values , Reproducibility of Results , Sensitivity and Specificity
19.
Asian Pac J Allergy Immunol ; 19(1): 23-7, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11495296

ABSTRACT

Complement Receptor 1 (CR1) is a polymorphic glycoprotein expressed on erythrocytes, leukocytes and glomerular podocytes and has a major role in immune complex processing. In addition, it regulates the complement cascade activation by preventing formation of classical and alternative pathway convertases and by acting as a cofactor for Factor I mediated cleavage of C3. In this study, we have examined the expression of erythrocyte CR1 (E-CR1) and glomerular CR1 (G-CR1) in different kinds of nephropathies using ELISA and immunofluorescence microscopy to understand their role in immune complex (IC) mediated renal diseases. E-CR1 was significantly reduced in all categories of lupus nephritis in comparison to normal subjects and non-IC renal diseases. However, other IC mediated diseases like IgA nephropathy and membranoproliferative glomerulonephritis had normal E-CR1 levels. G-CR1 showed distinct differences between IC and non-IC mediated diseases. G-CR1 was virtually absent in lupus kidneys. In other IC mediated diseases, there was a correlation of G-CR1 expression to the IC and complement fragment deposition. G-CR1 serves as a useful diagnostic marker for IC mediated diseases while E-CR1 is useful as a prognostic marker to monitor the course of disease after the treatment has initiated.


Subject(s)
Immune Complex Diseases/diagnosis , Kidney Diseases/diagnosis , Kidney Glomerulus , Receptors, Complement 3b/analysis , Receptors, Complement/analysis , Erythrocytes/chemistry , Female , Follow-Up Studies , Humans , India , Kidney Diseases/immunology , Male , Methods , Prognosis
20.
Indian Heart J ; 53(2): 224-30, 2001.
Article in English | MEDLINE | ID: mdl-11428485

ABSTRACT

There is abundant epidemiological and clinical evidence to show that light-to-moderate drinking is associated with a reduced risk of coronary heart disease (CHD), total and ischemic stroke, and total mortality in middle-aged and elderly men and women. The evidence suggests a J- or U-shaped relationship between alcohol and CHD. Alcohol reduces the risk of coronary heart disease both by inhibiting the formation of atheroma and by decreasing the rate of blood coagulation. It appears that for most conditions, other than cardiovascular diseases and cholelithiasis, moderate alcohol consumption has either none or only an intermediate type of risk as compared with the risk of either abstinence or excessive drinking. It is now fully recognized and accepted that drinking alcohol regularly for years is toxic to almost every tissue of the body. However, most people who choose to drink alcohol have little or no problem limiting their consumption to amounts that do not generally cause serious health or social consequences. Moreover, a given dose of alcohol may affect different people differently. It is, therefore, imperative that a critical evaluation, based on the observations made hitherto, be done of both the harmful and the protective effects of alcohol consumption on various organs/systems of the body. This article reviews epidemiological evidence for the protective effects of alcohol on the cardiovascular system and discusses how alcohol might lower the risk of CHD.


Subject(s)
Alcohol Drinking , Coronary Disease/prevention & control , Female , Humans , Male , Prognosis , Risk Assessment , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...